Tina Ventura | Horizon Pharma Plc |
Timothy P. Walbert | Horizon Pharma Plc |
Paul W. Hoelscher | Horizon Pharma Plc |
Shao-Lee Lin | Horizon Pharma Plc |
Vikram Karnani | Horizon Pharma Plc |
Robert F. Carey | Horizon Pharma Plc |
Eric Mosbrooker | Horizon Pharma Plc |
Ken Cacciatore | Cowen & Co. LLC |
David A. Amsellem | Piper Jaffray & Co. |
Marc Goodman | UBS Securities LLC |
Gary Nachman | BMO Capital Markets (United States) |
Annabel Eva Samimy | Stifel, Nicolaus & Co., Inc. |
Dana Flanders | Goldman Sachs & Co. LLC |
Brandon Folkes | Cantor Fitzgerald Securities |
Good morning and thank you for standing by. Welcome to the Horizon Pharma plc Fourth Quarter and Full Year 2017 Earnings Conference Call.
As a reminder, today's conference call is being recorded. I would now like to introduce Ms. Tina Ventura, Senior Vice President of Investor Relations.